Insider Trading History of Wells David R.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Wells David R. since 2010. This trader's CIK number is 1480371. At the time of last reporting, Wells David R. was the Chief Financial Officer of Endra Life Sciences Inc.. (stock ticker symbol NDRA). Also see all insider trading activities at Endra Life Sciences Inc..

Note that in the past Wells David R. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Endra Life Sciences Inc. (NDRA) by Wells David R.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 NDRA 0 $0 35,000 $31,500 0 $0
2019 NDRA 20,000 $27,350 0 $0 0 $0

Yearly summary of insider trading at Sionix Corp (SINX) by Wells David R.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 SINX 20,833 $999 0 $0 0 $0
2010 SINX 89,636 $13,957 0 $0 0 $0


Insider trading activities at 2 companies by Wells David R.:

1. Endra Life Sciences Inc. (NDRA)

2. Sionix Corp (SINX)

Table 1. Insider trading of Endra Life Sciences Inc. (NDRA) by Wells David R.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-01-06 NDRA Sale 34,900 .90 31,410
2021-01-05 NDRA Sale 100 .90 90
2019-09-27 NDRA Buy 10,000 1.18 11,800
2019-08-22 NDRA Buy 5,000 1.56 7,800
2019-08-23 NDRA Buy 5,000 1.55 7,750

Table 2. Insider trading of Sionix Corp (SINX) by Wells David R.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-01-03 SINX Buy 20,833 .05 999
2010-12-15 SINX Buy 22,222 .04 999
2010-11-15 SINX Buy 15,386 .07 1,000
2010-12-01 SINX Buy 16,666 .06 999
2010-10-15 SINX Buy 18,181 .55 9,963
2010-11-01 SINX Buy 17,181 .06 996

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wells David R. (Chief Financial Officer of Endra Life Sciences Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.